No new items were published in the sources we monitor on this date. The open consultations and hearings below remain current.
Federal Official Gazette
No changes.
ANS news
No changes.
Open public consultations
- CP 175. Subject: criticisms and suggestions regarding the preliminary recommendations against incorporating the technologies covered by UAT No. 199 – Cholangioscopy, UAT No. 200 – Next-generation sequencing (NGS) panel and UAT No. 206 – Tepotinib hydrochloride. Deadline: Aug 12, 2026 to Aug 31, 2026
Scheduled public hearings
- AP 68. Subject: preliminary recommendation against incorporating the technologies covered by UAT No. 199 – Cholangioscopy, UAT No. 200 – Next-generation sequencing (NGS) panel and UAT No. 206 – Tepotinib hydrochloride. Date: August 20, 2026, from 9:00 a.m. to 1:00 p.m., virtually, via the Microsoft Teams platform.
Open public calls for input
There is no open public call for input.
Open public calls
Discount cards, prepaid cards, or related services. Deadline: From Jun 2, 2026 to Aug 18, 2026.
Other news
– No changes.
Sources: Federal Official Gazette (DOU) and the ANS website. Press items link to the original article. This brief is for information only and does not constitute legal advice.